Pravin Dugel - Feb 11, 2025 Form 4 Insider Report for OCULAR THERAPEUTIX, INC (OCUL)

Role
Executive Chairman, President and CEO, Director
Signature
/s/ Donald Notman, Attorney-in-Fact for Pravin Dugel
Stock symbol
OCUL
Transactions as of
Feb 11, 2025
Transactions value $
$0
Form type
4
Date filed
2/13/2025, 08:38 PM
Previous filing
Nov 27, 2024
Next filing
Feb 26, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUL Common Stock Award $0 +1.25M +157.87% $0.00 2.04M Feb 11, 2025 Direct F1
transaction OCUL Common Stock Award $0 +1.5M +73.46% $0.00 3.54M Feb 11, 2025 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 11, 2025 (the "Grant Date"), the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended (the "2021 Plan"), of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the Grant Date and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter.
F2 On the Grant Date, the reporting person was granted performance stock units ("PSUs") under the 2021 Plan and in accordance with a PSU award agreement (the "PSU Award Agreement").
F3 Each PSU represents a right to receive one share of the Corporation's common stock. Pursuant to the PSU Award Agreement, the shares underlying the PSUs can be earned during the five-year period beginning on the Grant Date in four equal tranches based on the achievement of share price hurdles if the Company's consecutive 60-day closing share price average meets or exceeds $15.00, $20.00, $25.00, and $30.00 per share (each, a "Share Price Hurdle"). Shares underlying the PSUs that are earned shall vest on the later of (i) the achievement of the applicable Share Price Hurdle or (ii) the three-year anniversary of the Grant Date, in each case subject to the reporting person's continued service to the Corporation. The PSUs are subject to earlier vesting upon certain qualifying termination events pursuant to the PSU Award Agreement.

Remarks:

Executive Chairman, President and CEO